Skip to main navigation Skip to search Skip to main content

Cardioversion procedure for atrial fibrillation patients revealing the costs associated with warfarin compared to the new oral anticoagulants (NOAC).

  • M. O'Shea (Speaker)
  • Kirby, A. (Speaker)
  • Aileen Murphy (Speaker)
  • G. Allen (Speaker)
  • G. Fahy (Speaker)

Activity: Talk or presentation › Oral presentation

Period9 Dec 2015
Event title UCC School of Economics Oral Presentation
Event typeConference
LocationCork, IrelandShow on map